 | • レポートコード：QYR9ST03480 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、性的機能不全治療薬の世界市場について調査・分析し、性的機能不全治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口療法、海綿体内療法、ホルモン療法、経尿道療法）、用途別（男性、女性）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の性的機能不全治療薬市場動向 ・主要企業別マーケットシェア ・性的機能不全治療薬の種類別市場規模2014-2019 （経口療法、海綿体内療法、ホルモン療法、経尿道療法） ・性的機能不全治療薬の用途別市場規模2014-2019 （男性、女性） ・性的機能不全治療薬の北米市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬の中国市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬のインド市場：主要企業・種類別/用途別市場規模 ・性的機能不全治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、GlaxoSmithKline、Merck、Eli Lilly、AbbVie、Bayer、Teva Pharmaceutical Industries、Takeda、Apricus Biosciences、Emotional Brain、Ivix LLX、Leadiant Biosciences、NexMed、S1 Biopharma、Vietstar Biomedical Research） ・性的機能不全治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.
In 2018, the global Sexual Dysfunction Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexual Dysfunction Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
Market segment by Type, the product can be split into
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players.
To present the Sexual Dysfunction Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Sexual Dysfunction Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sexual Dysfunction Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Therapy
1.4.3 Intracavernosal Therapy
1.4.4 Hormonal Therapy
1.4.5 Transurethral Therapy
1.5 Market by Application
1.5.1 Global Sexual Dysfunction Drugs Market Share by Application (2014-2025)
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sexual Dysfunction Drugs Market Size
2.2 Sexual Dysfunction Drugs Growth Trends by Regions
2.2.1 Sexual Dysfunction Drugs Market Size by Regions (2014-2025)
2.2.2 Sexual Dysfunction Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sexual Dysfunction Drugs Market Size by Manufacturers
3.1.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sexual Dysfunction Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Sexual Dysfunction Drugs Key Players Head office and Area Served
3.3 Key Players Sexual Dysfunction Drugs Product/Solution/Service
3.4 Date of Enter into Sexual Dysfunction Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sexual Dysfunction Drugs Market Size by Type (2014-2019)
4.2 Global Sexual Dysfunction Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Sexual Dysfunction Drugs Market Size (2014-2019)
5.2 Sexual Dysfunction Drugs Key Players in United States
5.3 United States Sexual Dysfunction Drugs Market Size by Type
5.4 United States Sexual Dysfunction Drugs Market Size by Application
6 Europe
6.1 Europe Sexual Dysfunction Drugs Market Size (2014-2019)
6.2 Sexual Dysfunction Drugs Key Players in Europe
6.3 Europe Sexual Dysfunction Drugs Market Size by Type
6.4 Europe Sexual Dysfunction Drugs Market Size by Application
7 China
7.1 China Sexual Dysfunction Drugs Market Size (2014-2019)
7.2 Sexual Dysfunction Drugs Key Players in China
7.3 China Sexual Dysfunction Drugs Market Size by Type
7.4 China Sexual Dysfunction Drugs Market Size by Application
8 Japan
8.1 Japan Sexual Dysfunction Drugs Market Size (2014-2019)
8.2 Sexual Dysfunction Drugs Key Players in Japan
8.3 Japan Sexual Dysfunction Drugs Market Size by Type
8.4 Japan Sexual Dysfunction Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sexual Dysfunction Drugs Market Size (2014-2019)
9.2 Sexual Dysfunction Drugs Key Players in Southeast Asia
9.3 Southeast Asia Sexual Dysfunction Drugs Market Size by Type
9.4 Southeast Asia Sexual Dysfunction Drugs Market Size by Application
10 India
10.1 India Sexual Dysfunction Drugs Market Size (2014-2019)
10.2 Sexual Dysfunction Drugs Key Players in India
10.3 India Sexual Dysfunction Drugs Market Size by Type
10.4 India Sexual Dysfunction Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Sexual Dysfunction Drugs Market Size (2014-2019)
11.2 Sexual Dysfunction Drugs Key Players in Central & South America
11.3 Central & South America Sexual Dysfunction Drugs Market Size by Type
11.4 Central & South America Sexual Dysfunction Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sexual Dysfunction Drugs Introduction
12.1.4 Pfizer Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sexual Dysfunction Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sexual Dysfunction Drugs Introduction
12.3.4 Merck Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sexual Dysfunction Drugs Introduction
12.4.4 Eli Lilly Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 AbbVie
12.5.1 AbbVie Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sexual Dysfunction Drugs Introduction
12.5.4 AbbVie Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.5.5 AbbVie Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sexual Dysfunction Drugs Introduction
12.6.4 Bayer Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Teva Pharmaceutical Industries
12.7.1 Teva Pharmaceutical Industries Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sexual Dysfunction Drugs Introduction
12.7.4 Teva Pharmaceutical Industries Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Industries Recent Development
12.8 Takeda
12.8.1 Takeda Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sexual Dysfunction Drugs Introduction
12.8.4 Takeda Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.8.5 Takeda Recent Development
12.9 Apricus Biosciences
12.9.1 Apricus Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sexual Dysfunction Drugs Introduction
12.9.4 Apricus Biosciences Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.9.5 Apricus Biosciences Recent Development
12.10 Emotional Brain
12.10.1 Emotional Brain Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sexual Dysfunction Drugs Introduction
12.10.4 Emotional Brain Revenue in Sexual Dysfunction Drugs Business (2014-2019)
12.10.5 Emotional Brain Recent Development
12.11 Ivix LLX
12.12 Leadiant Biosciences
12.13 NexMed
12.14 S1 Biopharma
12.15 Vietstar Biomedical Research
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Sexual Dysfunction Drugs Key Market Segments
Table Key Players Sexual Dysfunction Drugs Covered
Table Global Sexual Dysfunction Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sexual Dysfunction Drugs Market Size Market Share by Type 2014-2025
Figure Oral Therapy Figures
Table Key Players of Oral Therapy
Figure Intracavernosal Therapy Figures
Table Key Players of Intracavernosal Therapy
Figure Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Figure Transurethral Therapy Figures
Table Key Players of Transurethral Therapy
Table Global Sexual Dysfunction Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Male Case Studies
Figure Female Case Studies
Figure Sexual Dysfunction Drugs Report Years Considered
Table Global Sexual Dysfunction Drugs Market Size 2014-2025 (Million US$)
Figure Global Sexual Dysfunction Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sexual Dysfunction Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Sexual Dysfunction Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Sexual Dysfunction Drugs Market Share by Regions 2014-2019
Figure Global Sexual Dysfunction Drugs Market Share by Regions 2014-2019
Figure Global Sexual Dysfunction Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Sexual Dysfunction Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sexual Dysfunction Drugs Market Share by Manufacturers (2014-2019)
Figure Global Sexual Dysfunction Drugs Market Share by Manufacturers in 2018
Table Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sexual Dysfunction Drugs Product/Solution/Service
Table Date of Enter into Sexual Dysfunction Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Sexual Dysfunction Drugs Market Size Share by Type (2014-2019)
Figure Global Sexual Dysfunction Drugs Market Size Market Share by Type (2014-2019)
Table Global Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Sexual Dysfunction Drugs Market Size Share by Application (2014-2019)
Figure Global Sexual Dysfunction Drugs Market Size Market Share by Application (2014-2019)
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Application in 2018
Figure United States Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table United States Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table United States Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure Europe Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table Europe Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table Europe Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure China Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table China Sexual Dysfunction Drugs Market Size by Type (2014-20189) (Million US$)
Table China Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table China Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table China Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure Japan Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table Japan Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table Japan Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table Southeast Asia Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table Southeast Asia Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure India Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table India Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table India Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table India Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table India Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Figure Central & South America Sexual Dysfunction Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sexual Dysfunction Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sexual Dysfunction Drugs Market Share (2018-2019)
Table Central & South America Sexual Dysfunction Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sexual Dysfunction Drugs Market Share by Type (2014-2019)
Table Central & South America Sexual Dysfunction Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sexual Dysfunction Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Sexual Dysfunction Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Bayer Company Details
Table Bayer Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Bayer Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Takeda Company Details
Table Takeda Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Takeda Recent Development
Table Apricus Biosciences Company Details
Table Apricus Biosciences Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Apricus Biosciences Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Apricus Biosciences Recent Development
Table Emotional Brain Company Details
Table Emotional Brain Revenue in Sexual Dysfunction Drugs Business (2014-2019)(Million US$)
Figure Emotional Brain Revenue Growth Rate in Sexual Dysfunction Drugs Business (2014-2019)
Table Emotional Brain Recent Development
Table Ivix LLX Company Details
Table Leadiant Biosciences Company Details
Table NexMed Company Details
Table S1 Biopharma Company Details
Table Vietstar Biomedical Research Company Details
Table Global Sexual Dysfunction Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Sexual Dysfunction Drugs Market Size Share by Regions (2019-2025)
Figure Global Sexual Dysfunction Drugs Market Size Share by Regions in 2025
Figure United States Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sexual Dysfunction Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Sexual Dysfunction Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Sexual Dysfunction Drugs Market Size by Product (2019-2025)
Figure Global Sexual Dysfunction Drugs Market Size by Product in 2025
Table Global Sexual Dysfunction Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Sexual Dysfunction Drugs Market Size by Application (2019-2025)
Figure Global Sexual Dysfunction Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の紫斑療法薬市場：専門的調査 Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis The global Purpura Therapy Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing…- 世界の勃起不全薬市場：動向・競争分析 Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-…
- 感情療法ロボットの世界市場：市場規模・現状・予測 Emotional therapy robots simulate a pet or a toy. One of the drives of the market is increase in healthcare spending. In 2018, the global Emotional Therapy Robots market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This r…
- ムコ多糖症遺伝子治療の世界市場：市場規模・現状・予測 Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 理学療法サービスの世界市場：市場規模・現状・予測 Physical therapy is one of the allied health professions that, by using mechanical force and movements, manual therapy, exercise therapy, and electrotherapy, remediates impairments and promotes mobility and function.Physical therapy is used to improve a patient's quality of life through examination,…